Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

terminated133%
unknown133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
completed

Comparative Effectiveness of Peripheral Nerve Blocks for Outpatient Shoulder Surgery

NCT03309644
terminatedphase_4

Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty

NCT03182933
unknownnot_applicable

Total Hip Arthroplasty: Multiple Blocks by UltraSound

NCT01276925

Clinical Trials (3)

Showing 3 of 3 trials
NCT03309644

Comparative Effectiveness of Peripheral Nerve Blocks for Outpatient Shoulder Surgery

Completed
NCT03182933Phase 4

Liposomal Bupivacaine Versus Standard Bupivacaine in the Adductor Canal for Total Knee Arthroplasty

Terminated
NCT01276925Not Applicable

Total Hip Arthroplasty: Multiple Blocks by UltraSound

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3